This inventor holds 3 USPTO granted patents. Top assignee: University of Kentucky Research Foundation. Active years: 1997-1998.
Company Filing History:
Years Active: 1997-1998
Title: Innovations of Krishnan Rajagopalan
Introduction
Krishnan Rajagopalan is an accomplished inventor based in Lexington, KY (US). He has made significant contributions to the field of biochemistry, particularly in the development of novel compounds that enhance the functionality of antibodies. His work has led to the filing of multiple patents, showcasing his innovative approach to scientific challenges.
Latest Patents
Rajagopalan holds 3 patents related to nucleotide or nucleoside photoaffinity compound modified antibodies. His latest patents focus on sites on antibodies that have an affinity for photoaffinity compounds, specifically purine or azidopurine containing compounds. These patents describe how these sites can facilitate the site-specific attachment of nucleotide photoaffinity compounds to antibodies, such as ATP- or GTP-analog photoaffinity compounds, through photochemical means. The resulting conjugates can be utilized for therapeutic or diagnostic purposes, demonstrating the potential impact of his innovations in medical applications.
Career Highlights
Rajagopalan is affiliated with the University of Kentucky Research Foundation, where he continues to advance his research and development efforts. His work has not only contributed to the scientific community but has also paved the way for new therapeutic strategies in medicine.
Collaborations
Throughout his career, Rajagopalan has collaborated with notable colleagues, including Heinz Kohler and Boyd Eugene Haley. These partnerships have enriched his research and expanded the scope of his innovative projects.
Conclusion
Krishnan Rajagopalan's contributions to the field of biochemistry through his patents and research at the University of Kentucky Research Foundation highlight his role as a leading inventor. His work in developing photoaffinity compound modified antibodies has the potential to revolutionize therapeutic and diagnostic applications.